A Long-Term Study Evaluating the Effects of Nicorandil Treatment on Duchenne Muscular Dystrophy-Associated Cardiomyopathy in Mice
Background: Duchenne muscular dystrophy (DMD) is a neuromuscular disease caused by dystrophin gene mutations affecting striated muscle. Due to advances in skeletal muscle treatment, cardiomyopathy has emerged as a leading cause of death. Previously, nicorandil, a drug with antioxidant and nitrate-li...
Main Authors: | Melanie Gartz PhD, MS, MHS, Margaret Haberman BS, Mariah J. Prom BS, Margaret J. Beatka BS, Jennifer L. Strande MD, PhD, Michael W. Lawlor MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-03-01
|
Series: | Journal of Cardiovascular Pharmacology and Therapeutics |
Online Access: | https://doi.org/10.1177/10742484221088655 |
Similar Items
-
Cardioprotective effect of nicorandil on isoproterenol induced cardiomyopathy in the Mdx mouse model
by: Rachel T. Sullivan, et al.
Published: (2021-06-01) -
The Relationship Between Sexual Function and Quality of Sleep in Caregiving Mothers of Sons with Duchenne Muscular Dystrophy
by: Karen T. Nozoe, et al.
Published: (2014-08-01) -
Gene Therapy Rescues Cardiac Dysfunction in Duchenne Muscular Dystrophy Mice by Elevating Cardiomyocyte Deoxy-Adenosine Triphosphate
by: Stephen C. Kolwicz, Jr., PhD, et al.
Published: (2019-11-01) -
Increased Rates of Vitamin D Insufficiency in Boys With Duchenne Muscular Dystrophy Despite Higher Vitamin D Supplementation
by: Qian Bian MD, et al.
Published: (2019-03-01) -
Cardiomyopathy secondary to Duchenne muscular dystrophy in children
by: Iulia Rodoman, et al.
Published: (2021-06-01)